Launch Tech Co Ltd Stock

• Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut

Takeda Pharmaceutical (NYSE:TAK) reported fiscal 2025 results that management described as solid despite pressure from generic

• 3 small-cap biotechs with potential breakthroughs in 2024

Amylyx Pharmaceuticals (NASDAQ:AMLX) is preparing for a pivotal Phase 3 readout for AVEXITIDE, its lead asset for post-bariatric

Abeona Therapeutics (NASDAQ:ABEO) reported early commercial momentum for ZEVASKYN in the first quarter of 2026, with executives highlighting new patient treatments, expanded treatment-center

• BridgeBio's Volatile Week Puts Biotech Stocks Under a Microscope

BridgeBio Pharma (NASDAQ:BBIO) executives used a BofA healthcare conference appearance in Las Vegas to reiterate confidence in the

• Acadia Pharmaceuticals: A Mid-Cap Biotech Making Large Moves

ACADIA Pharmaceuticals (NASDAQ:ACAD) executives said the company is focused on expanding its two commercial brands while preparing for

• Boarding Passes Now Being Issued for the Ultimate eVTOL Arbitrage

Archer Aviation (NYSE:ACHR) executives said the company is increasing investment across its civil air taxi, defense and aviation

Rekor Systems (NASDAQ:REKR) said its first-quarter results reflected early benefits from a broad cost-reduction effort, while management pointed to stronger margins, higher recurring revenue and a

ESAB (NYSE:ESAB) reported what management described as a strong start to 2026, with record first-quarter sales and reaffirmed full-year guidance despite higher costs tied to the conflict in Iran

• MarketBeat’s Top 5 Rated Small-Cap Stocks

Trevi Therapeutics (NASDAQ:TRVI) outlined plans to advance Haduvio, its extended-release formulation of nalbuphine, across multiple chronic cough

Stoke Therapeutics (NASDAQ:STOK) said its lead investigational therapy zorevunersen continued to show durable seizure reductions and improvements in measures of cognition and behavior in four-year

• 3 Beaten-Down Stocks With Rebound Potential This Earnings Season

Scholar Rock (NASDAQ:SRRK) said the U.S. Food and Drug Administration has accepted for review its resubmitted Biologics License

In early April, the Trump administration proposed an increase in defense spending to $1.5 trillion for 2027. This was the largest such request in decades and would mark a 44% increase for the

Despite putting up wildly different performances lately, big names across semiconductors, entertainment, and e-commerce are indicating significant confidence in their outlooks through recent

The artificial intelligence (AI) market is undergoing a rapid evolution. For the past two years, investor capital has heavily favored trillion-dollar hardware manufacturers and broad, text-based